全文获取类型
收费全文 | 211713篇 |
免费 | 29832篇 |
国内免费 | 7002篇 |
专业分类
耳鼻咽喉 | 1755篇 |
儿科学 | 2849篇 |
妇产科学 | 5569篇 |
基础医学 | 15384篇 |
口腔科学 | 2381篇 |
临床医学 | 17852篇 |
内科学 | 20451篇 |
皮肤病学 | 1460篇 |
神经病学 | 1365篇 |
特种医学 | 6399篇 |
外国民族医学 | 256篇 |
外科学 | 29296篇 |
综合类 | 27422篇 |
现状与发展 | 39篇 |
一般理论 | 4篇 |
预防医学 | 10869篇 |
眼科学 | 627篇 |
药学 | 15123篇 |
137篇 | |
中国医学 | 5266篇 |
肿瘤学 | 84043篇 |
出版年
2024年 | 193篇 |
2023年 | 4402篇 |
2022年 | 6177篇 |
2021年 | 10915篇 |
2020年 | 10935篇 |
2019年 | 10034篇 |
2018年 | 9624篇 |
2017年 | 10046篇 |
2016年 | 10724篇 |
2015年 | 12311篇 |
2014年 | 17831篇 |
2013年 | 17777篇 |
2012年 | 14175篇 |
2011年 | 14368篇 |
2010年 | 10473篇 |
2009年 | 10568篇 |
2008年 | 10855篇 |
2007年 | 10179篇 |
2006年 | 8970篇 |
2005年 | 7352篇 |
2004年 | 6102篇 |
2003年 | 5112篇 |
2002年 | 4297篇 |
2001年 | 3961篇 |
2000年 | 3256篇 |
1999年 | 2658篇 |
1998年 | 2072篇 |
1997年 | 1832篇 |
1996年 | 1496篇 |
1995年 | 1538篇 |
1994年 | 1301篇 |
1993年 | 998篇 |
1992年 | 870篇 |
1991年 | 801篇 |
1990年 | 587篇 |
1989年 | 554篇 |
1988年 | 453篇 |
1987年 | 402篇 |
1986年 | 303篇 |
1985年 | 416篇 |
1984年 | 340篇 |
1983年 | 232篇 |
1982年 | 241篇 |
1981年 | 223篇 |
1980年 | 191篇 |
1979年 | 118篇 |
1978年 | 83篇 |
1977年 | 68篇 |
1976年 | 63篇 |
1975年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
51.
52.
《Drug discovery today》2022,27(9):2551-2561
B cell lymphoma 2 (BCL2) overexpression in a range of human tumors is often related to chemotherapy resistance and poor prognosis. GC-rich regions upstream of the P1 promoter in human BCL2 can form G-quadruplex (G4) structures through the stacking of four Hoogsteen-paired guanine bases. Stabilizing the G4 fold implies the inhibition of BCL2 expression and, thus, small molecules that selectively bind to the G4 are promising anticancer candidates. In this review, we discuss the structural aspects, binding affinity, selectivity, and biological activity of well-characterized BCL2 G4 binding ligands in vitro and in vivo. We also explore future directions in the research and development of G4-based anticancer therapeutics. 相似文献
53.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
54.
55.
胃癌作为临床最常见的肿瘤之一,常因确诊疾病较晚而影响治疗效果,胃镜活检后的病理虽然作为确诊的金标准,但是由于此方式过程痛苦,操作复杂,费用较高,且具有侵入性,可能会导致患者拒绝操作而难普及于临床,因此积极找寻胃癌有效的监测指标十分必要。近年来,很多学者研究维生素与胃癌的相关关系,并试图通过摄取某些维生素降低胃癌发生率,延缓病情及改善预后,也有通过检测血清中维生素的水平给早期胃癌的诊断提供帮助。本文就同型半胱氨酸、维生素D、维生素C、维生素E、维生素B12及叶酸在胃癌中的作用机制,及其在血清中水平与胃癌关系的相关研究进展进行简要综述,为临床胃癌诊疗提供新思路。 相似文献
56.
目的:本研究通过检测前列腺特异性膜抗原(prostate specific membrane antigen,PSMA)-肿瘤特异性嵌合抗原受体(chimeric antigen receptor,CAR)-细胞因子诱导的杀伤细胞(cytokine induced killer cell,CIK)转基因细胞杀伤三种前列腺癌细胞株的效率,鉴定其用于后期治疗前列腺癌的可行性。方法:通过已经构建的二代PSMA-CAR慢病毒表达载体转染CIK细胞,构建PSMA-CAR-CIK转基因细胞;通过CCK8法检测CIK细胞及PSMA-CAR-CIK转基因细胞杀伤三种前列腺癌细胞株PC3、LNCaP、DU145的效率及效靶比。结果:转基因PSMA-CAR-CIK细胞构建成功;3 h~3.5 h为检测效应细胞对靶细胞细胞毒活性时与CCK8试剂孵育的最佳时间;两种效应细胞均在效靶比为10∶1、15∶1、20∶1时,杀伤率逐步增高,无统计学意义(P>0.05),但与其它组相比差异显著(P<0.05)。结论:两种效应细胞对于前列腺癌细胞的杀伤,只要效靶比达到10∶1的比例,就能起到一个较好的杀瘤效果,并且随着效应细胞的增加,其抗肿瘤能力逐步加强;转基因PSMA-CAR-CIK细胞的构建为CAR技术治疗前列腺癌的临床应用奠定了基础。 相似文献
57.
Geographic Characteristics of Various Cancers in Yogyakarta Province,Indonesia: A Spatial Analysis at the Community Level 下载免费PDF全文
Solikhah SolikhahDyah Aryani PerwitasariDwi Sarwani Sri Rejeki 《Asian Pacific journal of cancer prevention》2022,23(4):1231-1238
Background: Cancer remains a significant public health problem in Indonesia and worldwide. Yogyakarta Province has the largest number of cancer cases in Indonesia. Maps of the distribution of cancer cases are useful tools for stratification of cancer risk and for selective prevention strategies. The aim of this study was to determine the spatial distribution of cancer cases in Yogyakarta Province. Methods: Cancer patient data registered by the Yogyakarta Provincial Health Office during 2019-2020 were analysed in this study (n=9,933). To evaluate cancer pattern distributions, ArcGIS 10.2 and Excel 2016 software were used. Results: The mean participant age (± standard deviation) was 55.08 ± 15.46 years, and 79.40% were female. Breast and cervical cancer were the most frequently diagnosed, and the majority of patients were located in Sleman district. The incidence of all cancer types varied by county-level. The majority of cancer patients lived below the poverty line. Cancer screening rates were low, and screening was limited to breast and cervical cancer. Conclusion: Various types of cancers were identified in Yogyakarta, Indonesia; of them, breast and cervical cancer predominated. Most of the cancer patients were from Sleman district and economically poor areas. Geospatial techniques are useful for identifying environmental factors related to cancer and improving cancer control strategies and resource allocation. 相似文献
58.
59.
《European journal of surgical oncology》2022,48(8):1778-1784
BackgroundThis study aimed to investigate which gastric cancer patients could benefit the most from staging laparoscopy.MethodsA retrospective cohort study was carried out, including 316 (216 cM- and 100 cM+) gastric cancer patients who had undergone staging laparoscopy between 2010 and 2020 in seven GIRCG centers. A model including easily-accessible clinical, biochemical and pathological markers was constructed to predict the risk of carcinomatosis. ROC curve and decision curve analyses were used to verify its accuracy and net benefit.ResultsIn the cM-population staging laparoscopy could detect 67 cases who had peritoneal carcinomatosis or positive cytology, for a yield of 30.5%. In cM-patients, intestinal type tumors (0.25, 0.12–0.51; p = 0.002), cT4 tumors (2.18, 1.11–4.28; p = 0.023) and cancers of the lower third (0.31, 0.14–0.70; p = 0.004) were associated with the presence of peritoneal carcinomatosis and/or positive cytology. The ROC curve analysis of the model including the three variables showed an AUC of 0.75 (0.68–0.81, p < 0.001). The decision curve analyses showed that the model had a higher net benefit than the treating all strategy between threshold probabilities of 15 and 50%.ConclusionsStaging laparoscopy is a useful tool to address the patient with gastric cancer to the most adequate treatment. In cM-patients the assessment of the location of the tumor, the Lauren's histotype and the cT status may help in providing additional elements in indicating or not the use of staging laparoscopy. 相似文献
60.